Trial intelligence / Profile preview

Preemptive intravenous diphenhydramine to attenuate airway and cardiovascular reflexes during extubation in orthognathic surgery

IRCT20130304012695N3Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of diphenhydramine in postoperative pain, postoperative delirium (POD) and None, sponsored by Tehran University of Medical Sciences. Started Jul 2019; status: completed.

02

Drugs

diphenhydramine
03

Conditions

postoperative painpostoperative delirium (POD)

Beyond the preview

Go deeper on IRCT20130304012695N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130304012695N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call